@FierceBiotech: ICYMI Friday: Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen. Article | Follow @FierceBiotech
@JohnCFierce: Will Zika frenzy fuel an overnight vaccine R&D miracle? Don't bet on it. More | Follow @JohnCFierce
@DamianFierce: this man missed a huge opportunity in orthopedics. More from STAT | Follow @DamianFierce
> Cambridge, MA-based Ariad ($ARIA) says it has received FDA approval to launch a Phase I/II study of AP32788, a tyrosine kinase inhibitor for non-small cell lung cancer with specific mutations in EGFR or HER2. Release
> Synergy Pharmaceuticals ($SGYP) says it filed its first NDA, shooting for an approval of plecanatide in chronic idiopathic constipation. Report
> Exelixis' ($EXEL) kidney cancer treatment cabozantinib improved overall survival compared with everolimus in a Phase III trial, the company said. The drug is up for a final FDA decision by June 22. More
Medical Device News
@FierceMedDev: ICYMI: Philips taps transportation exec in its effort to industrialize, personalize healthcare. Article | Follow @FierceMedDev
@VarunSaxena2: Which pharma character is #1? FiercePharmaMarketing report | Follow @VarunSaxena2
@EmilyWFierce: Abbott inks $5.8B deal for Alere to expand in point-of-care diagnostics. Report | Follow @EmilyWFierce
> Smith & Nephew reveals its CEO has cancer, says he will remain in charge during treatment. News
> Stryker to buy disposable device maker for $2.7B to reduce hospital-acquired infections. Article
Pharma News
@FiercePharma: Lilly closes two animal health factories, citing no 'competitive business model.' FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: ICYMI from FiercePharmaManufacturing: Novartis is revamping its manufacturing after having disposed of 25 plants. Article | Follow @EricPFierce
@CarlyHFierce: ICYMI: Merck sets $54K list price for hep C combo as it preps for battle with Gilead, AbbVie. Article | Follow @CarlyHFierce
> Novartis braces for multibillion-dollar generics hit as Gleevec copies launch. Article
> Was Allergan's CEO simply touting a Texas plant expansion--or nudging watchdogs on Pfizer merger, too? More
> Roche sees no 'short term' pricing pressure for company's cancer drugs: Reuters. Story
Animal Health News
> Lilly closes two animal health factories, citing no 'competitive business model.' More
> IDEXX and Abaxis trade fortunes on Wall Street as earnings surprise investors. Story
> Merial teams with Georgia Tech to advance connected networks for animal health. Article
> Dog flu sweeps the U.S. with two more confirmed cases in Washington state. Report
> Aratana shares soar on first FDA filing for approval of canine arthritis drug. News
Biotech IT News
> CosmosID raises $6M to advance microbiome bioinformatics offering. Story
> BioClinica rolls out tech-enabled postapproval research service. Item
> DNAnexus connects genomics platform to Sapio Sciences' LIMS. More
> AstraZeneca taps CRISPR to extract value from genome data. Report
> Leo Pharma mounts $70M push into digital health technology. Article
Pharma Marketing News
> More link think? OPDP lists social media links as guidance item for 2016. Report
> Don't expect a generics-style smackdown from Remicade biosims, J&J CEO says. Story
> Novo's Tresiba scores data for a new edge in insulin fight against Sanofi. Article
> Roche's pharma chief sees no 'short term' pricing pressure on its cancer blockbusters. More
> Novartis retrains Entresto reps, plans field force expansion as payers finally step up. Report